Form S-1 Theriva Biologics, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom forecasts quarterly sales below estimates amid rising custom AI chip competition
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Theriva Biologics (TOVX) Files for 2.17M Share and Warrant Offering
September 10, 2024 5:07 PM EDTTheriva Biologics (NYSE: TOVX) has filed the following:
We are offering on a best efforts basis up to 2,173,913 shares of our common stock, par value $0.001 (the Common Stock), together with warrants to purchase up to 2,173,913 shares of our Common Stock. Each share of Common Stock, or a pre-funded warrant in lieu thereof, is being sold together with a common warrant to purchase one share of Common Stock (the Common Warrant). The shares of Common Stock and Common Warrants are immediately separable and will be issued separately in this offering,... More
